Medically reviewed by Doru Paul, MD Immunohistochemistry (IHC) is a special test used by pathologists to detect specific molecules on cells. It is widely used in clinical oncology for categorizing ...

While all steps in the IHC protocol affect the quality of the staining outcome, three important factors to consider during initial optimization are primary antibody selection, antigen retrieval, and ...

The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

Burmer is a molecular pathologist, and a founder of antibody provider Lifespan Biosciences. In the 25 years since the company’s launch, she estimates that LSBio has performed IHC testing on more ...

HER2-ultralow is defined as immunohistochemistry (IHC) 0 with membrane staining. T-DXd, an antibody-drug conjugate now approved for multiple tumor types, gained approval in 2022 for unresectable ...

Lunit’s model demonstrated 86.7% accuracy compared to pathologist assessments for HER2 immunohistochemistry ... 2-targeted therapy uses monoclonal antibodies (mAb) or tyrosine kinase inhibitors ...